SCHEMBL25818466

SCHEMBL25818466

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccc6ccccc6c5)cc4c3)c2)nc(-c2cccc3c2oc2ccccc23)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
GGPS1 O95749 1/20 0.35
PRKDC P78527 3/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
CYP2C9 P11712 1/20 0.34
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
AHR P35869 3/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22161554 0.95 ALOX5 (0.46) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL29739107 0.93 ALOX5 (0.44) ALOX5GGPS1PRKDCPIM1CSNK2A2
SCHEMBL25893321 0.93 ALOX5 (0.44) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL22889107 0.93 ALOX5 (0.48) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL22889401 0.91 ALOX5 (0.46) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL22889379 0.91 ALOX5 (0.46) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL26260475 0.91 ALOX5 (0.50) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL25818456 0.90 ALOX5 (0.42) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL27098254 0.90 ALOX5 (0.42) ALOX5GGPS1PRKDCCYP1A2CYP2C19
SCHEMBL22889351 0.90 ALOX5 (0.48) ALOX5GGPS1PRKDCCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALOX5 556/4885GGPS1 1681/4885PRKDC 4468/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALOX5 556/4885GGPS1 1681/4885PRKDC 4468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.